Atlas Trials

Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients

Clinical trial NCT00265226 · COMPLETED

Trial details

NCT number
NCT00265226
Sponsor
Ministry of Science and Technology, India
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Tuberculosis
Start date
2005-03-01
Primary completion
2010-12-01
Enrollment
1020

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.